Enimmune Corporation (TPEX:6564)
16.50
-0.20 (-1.20%)
Jul 14, 2026, 12:34 PM CST
6.80% (1Y)
| Market Cap | 1.19B +2.5% |
| Revenue (ttm) | 48.19M +20.7% |
| Net Income | -164.35M |
| EPS | -2.28 |
| Shares Out | 72.13M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 71,449 |
| Open | 16.25 |
| Previous Close | 16.70 |
| Day's Range | 16.25 - 16.65 |
| 52-Week Range | 14.65 - 23.90 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 11, 2026 |